2p33: Difference between revisions

No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
The development of a series of novel aminopyrimidines as inhibitors of, c-Jun N-terminal kinases is described. The synthesis, in vitro inhibitory, values for JNK1, JNK2 and CDK2, and the in vitro inhibitory value for a, c-Jun cellular assay are discussed.
The development of a series of novel aminopyrimidines as inhibitors of c-Jun N-terminal kinases is described. The synthesis, in vitro inhibitory values for JNK1, JNK2 and CDK2, and the in vitro inhibitory value for a c-Jun cellular assay are discussed.
 
==Disease==
Known diseases associated with this structure: Epileptic encephalopathy, Lennox-Gastaut type OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=602897 602897]]


==About this Structure==
==About this Structure==
Line 14: Line 17:
[[Category: Mitogen-activated protein kinase]]
[[Category: Mitogen-activated protein kinase]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Ceska, T.A.]]
[[Category: Ceska, T A.]]
[[Category: Dickson, K.M.]]
[[Category: Dickson, K M.]]
[[Category: Fortunato, M.]]
[[Category: Fortunato, M.]]
[[Category: Platt, A.]]
[[Category: Platt, A.]]
Line 23: Line 26:
[[Category: jnk3 kinase]]
[[Category: jnk3 kinase]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jan 23 14:50:15 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 18:25:27 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA